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ABSTRACT: Protein corona formed on the surface of nanoparticle in biological medium 
determines its behavior in vivo. Here, iron oxide nanoparticles containing the same core and 
shell, but bearing two different surface coatings, either glucose or poly(ethylene glycol), were 
evaluated. The nanoparticles protein adsorption, in vitro degradation, and in vivo biodistribution 
and biotransformation over four months, were investigated. Although both types of nanoparticles 
bound similar amount of proteins in vitro, the differences in the protein corona composition 
correlated to the nanoparticles biodistribution in vivo. Interestingly, in vitro degradation studies 
demonstrated faster degradation for nanoparticles functionalized with glucose, whereas the in 
vivo results were opposite with accelerated biodegradation and clearance of the nanoparticles 
functionalized with poly(ethylene glycol). Therefore, the variation in the degradation rate 
observed in vivo could be related not only to the molecules attached to the surface, but also with 
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the associated protein corona, as the key role of the adsorbed proteins on the magnetic core 
degradation has been demonstrated in vitro. 
KEYWORDS: iron oxide nanoparticles, protein corona, biodistribution, nanoparticles 
degradation, in vivo 
 
INTRODUCTION 
Up to day, iron oxide nanoparticles (IONPs) are one of the most studied nanomaterials for 
biomedical applications. The considerable interest in IONPs results from the combination of 
their unique magnetic properties, low toxicity and biodegradability.1 Therefore, they present a 
great potential for prominent nanomedicine applications such as external manipulation using 
magnets, multimodal imaging, triggered drug delivery or hyperthermia induced tumor ablation.2,3 
However, satisfactory employment of nanoparticles (NPs) in any of those applications has not 
been achieved yet mainly due to one hindrance, that is, controlling the behavior of NPs in vivo. 
Once a NP is administered in vivo, it interacts with the components of the physiological 
environment, specially with proteins, resulting in the formation of so-called protein corona 
(PC).4 PC can dramatically change the nanomaterial size, aggregation state and interfacial 
properties, dominating in an uncontrolled way the biological behavior of NPs.5  
 Although to date it is widely accepted that the presence of this PC would ultimately 
determine the fate of the nanomaterial, its role in the biotransformation and degradation of NPs 
in vivo has been scarcely investigated.6 In vitro, it has been shown that the PC can enter the cell 
attached to the NP, and later on, depending on the associated proteins, be destroyed with 
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different kinetics in the lysosomes.7 In vivo, it is known that once NPs are trapped in cells, their 
biodegradation process would greatly depend on different factors such as the capping agent, the 
clustering state or the recycling capacity of the organ.8,9 Only recently, a comparative study of 
two different coating shells for gold/iron heterostructures has demonstrated that poly(ethylene 
glycol) (PEG)-coated NPs were more vulnerable to degradation in vitro and in vivo than those 
NPs coated with oleic acid and a polymer, suggesting that this coating, and therefore the 
associated PC would have a protective role in the degradation of the NPs.8 However, the 
composition of the shell was different between both types of NPs, and therefore, the role of the 
diverse PCs cannot be clearly established.  
 Here, we provide evidence that the PC is the main responsible for the NPs fate and it is 
implicated in the NPs degradation process. We report how the surface modification of identical 
12 nm IONPs with either glucose or PEG affects the PC identity, the NPs biodistribution and 
more importantly, the degradation over time. 
 
RESULTS AND DISCUSSION 
IONPs synthesis and functionalization 
IONPs were synthesized following a previously reported seed-mediated growth method based on 
the thermal decomposition of Fe(III) acetylacetonate,10 as this method renders NPs with well-
controlled size and high crystallinity. In this case, 12 nm NPs were selected for the in vivo 
studies (Fig. S1) as this diameter will likely avoid renal clearance,11 allowing to track their 
biodistribution in vivo. The synthesis method provides NPs dispersed in an organic solvent, 
therefore a subsequent transfer to aqueous solution is required. For this purpose, modification of 
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a previously reported protocol was applied, where NPs were coated with an amphiphilic polymer 
shell (poly(maleic anhydride-alt-1-octadecene), PMAO).12,13,14 Using this methodology, the 
hydrophobic backbone of the polymer intercalates with the oleic acid chains that covers the NPs 
core, leaving carboxylic groups exposed to the solvent. In this case, to be able to track the NPs ex 
vivo, they were transferred into water using the PMAO polymer previously modified with a 
fluorophore, 5-carboxytetramethylrhodamine (TAMRA) (NPs@PMAO, Scheme S1).15 To 
provide stability in biological media, NPs@PMAO were functionalized with either glucose 
(NP@Glc) or PEG molecules (NPs@PEG), as those molecules have been previously 
demonstrated to efficiently passivate NPs surface avoiding aggregation in cell culture medium in 
vitro.16,17,18 There is a general consensus that protein adsorption and consequently biodistribution 
is highly dependent on the PEG molecular weight, therefore a long PEG of 5000 Da was chosen 
to passivate the surface of the NP. In fact it has been described that maximal reduction in protein 
adsorption is found for a PEG of 5000 Da.19 Other examples have also linked this PEG MW with 
the protein adsorption and consequently with the macrophage uptake. For instance, magnetic NP 
uptake by macrophages is higher for NPs coated with a PEG of 600 Da when compared to a PEG 
of 3000 Da.20 
It should be highlighted that NPs@Glc and NPs@PEG presented the same core size (Fig. S2a), 
shell structure and stability (in water, phosphate buffered saline or cell culture medium 
supplemented with 10% bovine serum), differing only in surface properties (Fig. S2b and S3). 
Therefore, these NPs were perfect candidates for an in vivo behavior comparative study, as in 
this case the adsorption of proteins and macrophage uptake would not be associated with the size 
of the NPs as previously reported.21  
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Associated protein corona characterization  
Before performing in vivo experiments, all three NPs types were incubated with serum proteins 
to form a PC, and further characterized to confirm the adsorption of proteins (Fig. S4). Protein 
quantification assay revealed that functionalization of the NP surface with either glucose or PEG 
molecules reduced significantly the amount of non-specifically adsorbed proteins in respect to 
the un-functionalized NPs@PMAO (Fig. 1a). This is of the highest importance, as the 
biodistribution and NP pharmacokinetic behavior in vivo can be strongly affected by the 
unspecific adsorption of plasma proteins.22,23 To determine the identity of the attached PC, the 
proteins were eluted from the surface of the NP, tryptic digested and the peptides were analyzed 
by mass spectrometry (LC-MS/MS).  372 different proteins were identified, and the specific 
proteins adsorbed to each NP and overlapping between them detected (Table S1-S4 and Fig. 
S5a) We next used the ingenuity pathway analysis software (IPA) for molecular and cellular 
function analysis for the identified unique proteins adsorbed to NPs@PEG and NPs@Glc. 29 
specific proteins adsorbed to NPs@PEG were mapped into 20 molecular and cellular functions 
(p value < 0.05), while 45 unique proteins absorbed to NPs@Glc were mapped into 28 molecular 
and cellular functions (p value < 0.05) (Table S5). We used the Venn diagram to evaluate those 
functions, which were specific for each type of NPs, and those functions that were common for 
both type of NPs. We observed 20 common molecular and cellular functions (Fig. S5b). Proteins 
absorbed to NPs@Glc mapped into 8 specific molecular and cellular functions. Further, and in 
order to investigate if the proteins bound onto NPs may be implicated in governing NP fate, the 
372 proteins detected by mass spectrometry were grouped according to their physiological 
function using UniProt database (Fig. 1b and Fig. S6).  
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The protein amounts were semi-quantitatively assessed by applying the spectral-counting method 
(SpC) in order to obtain the percentage of participating proteins in the PC composition (relative 
abundance). The normalized SpC amounts of each protein, which were identified in the LC-MS/ 
MS study, were calculated by applying the following equation:24,25 
 =

	

 () 
∑ 
 ()  
	100 
where NpSpCk is the normalized percentage of the spectral count for protein k, SpC is the 
identified spectral count, and Mw is the molecular weight (in kDa) of the protein k. This 
correction takes into account the protein size and evaluates the actual contribution of each 
protein reflecting its relative protein abundance in the protein corona (Fig. 1b and Fig. S6). 
 Interestingly, it was shown that although both types of functionalized NPs adsorbed similar 
amounts of proteins in vitro, NPs@Glc adsorbed more proteins considered opsonins (e.g. 
complement proteins, apolipoproteins). Indeed, a clear difference can be seen in the enrichment 
of complement components, which promotes clearance of NPs via interaction with macrophage 
complement receptors (Figure S6(a)).26 In fact the relative abundance is two times higher for 
NPs@Glc than for NPs@PEG. Fibronectin, also enriched in the PC of NPs@Glc when 
compared to the PC of NPs@PEG, has been also associated with an uptake by Kupffer cells.27 
Further, specific proteins considered opsonins (coagulation factor XI, mannose-binding protein 
C, C4b and fibrinogen) were only found in the PC of NPs@Glc. On the other hand, the relative 
abundance of proteins belonging to the coagulation and apolipoproteins group were comparable 
(Figure S6(b-c)). Among all detected acute phase proteins, NPs@PEG were found to bind more 
Page 7 of 44
ACS Paragon Plus Environment
ACS Applied Materials & Interfaces
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
  
8
α-2-HS-glycoprotein than NPs@Glc (Figure S6(d)). This protein has been described as a 
negative acute phase reactant with strong analogy to albumin, therefore, it is expected that it will 
act similarly, promoting elongation of NP circulation in the blood.27 Lastly, the corona of 
NPs@PEG was more enriched in albumin (dysopsonin), and other proteins such as kininogen 
that are associated with NPs covered with a high density of PEG.21 The enrichment of other 
components such as clusterin that is thought to be a “don’t-eat-me” protein has been found to be 
similar in both coronas.28 Although the precise effect of PC composition on NP fate in vivo 
remains unclear, proteins considered opsonins are thought to enhance recognition and uptake of 
NPs by macrophages resulting in their accumulation in the organs of mononuclear phagocyte 
system (MPS), mainly in the liver and spleen.29 Conversely, dysopsonins increase the half-life of 
molecules in the blood.27  
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Figure 1. Characterization of the proteins adsorbed to the NPs. (a) Quantitative analysis of the 
PC bound onto NPs@PMAO, NPs@Glc and NPs@PEG performed using Bicinchonic Acid 
(BCA)-assay. Black asterisks indicate NPs where the amount of adsorbed proteins is statistically 
different to the unfunctionalized NPs@PMAO (p < 0.001); ordinary one-way ANOVA, 
Dunnett's multiple comparisons test). (b) Relative abundance of the proteins adsorbed on 
NPs@Glc and NPs@PEG. The proteins were classified according to their physiological 
function: albumin; coagulation proteins; complement proteins; apolipoproteins; acute phase 
proteins; immune response proteins; transport proteins. 
In order to verify if the slight variation in the PC composition between NPs@Glc and NPs@PEG 
was correlated with their biodegradation and biological performance, a complete biodegradation 
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study was performed in vitro and in vivo. In vivo, the biodistribution of the NPs was previously 
assessed. 
In vitro degradation study 
In order to investigate if PC may be implicated in the degradation process, it was decided to use 
the unfunctionalized NPs, covered just with the polymer (NPs@PMAO) for the in vitro 
degradation study. The PC of those NPs is composed of a much higher amount of proteins than 
the one of the NPs@Glc or NPs@PEG (Fig. 1a), therefore it was supposed that the effect on the 
degradation should be more pronounced. NPs@PMAO with and without formed PC 
(NPs@PMAO-PC and NPs@PMAO, respectively) were incubated in a medium mimicking 
intracellular lysosomal environment (pH 4.7, 20 mM citrate)30  or in water (control). Afterwards, 
NPs were analyzed using transmission electron microscopy (TEM) and alternating current (AC) 
magnetic measurements. Whereas the first technique allows visual analysis of degradation 
process, AC magnetic measurements especially through the analysis of the out-of-phase 
susceptibility (χ″(T)) profile, constitute a powerful tool for both detection (see NPs 
biodistribution 72 h post-injection section) and over time biotransformation studies. The 
reduction of the χ″(T) maximum height, when plotted per mass of sample, is an indicator of the 
decrease of the NPs concentration in a given sample (Fig. 2a).31 The shift of the χ″(T) maximum 
location towards lower temperatures indicates the transformation of the iron core (Fig. 2b). 
Although there are other parameters that may influence the location in temperature of the χ″(T) 
maximum, in this case, the main factor associated to this transformation is the reduction of the 
particle size due to the degradation process.32,33 
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Figure 2. AC magnetic measurements schematic diagram. (a) Schematic representation of the 
processes associated to a reduction of the χ″(T) maximum height, indicating a decrease of the 
amount of NPs in a given sample. (b) Schematic representation of the process associated to a 
shift of the χ″(T) towards lower temperatures: reduction of the NPs core size. 
 
TEM observations showed that NPs@PMAO incubated in the lysosomal medium were 
degraded, in contrast to their PC-counterparts or the samples in water, that remained unalterable 
(Fig. 3a). Magnetic measurements (Fig. 3b) confirmed those results as the scaled χ″(T) 
maximum of the NPs@PMAO incubated in the lysosomal medium was clearly shifted towards 
lower temperatures on the contrast to other samples. Therefore, these results unambiguously 
demonstrate that the presence of PC on the surface of NPs provides protection against NP core 
degradation in the lysosomal medium. Detailed investigation of the degraded NPs showed that 
NP core, although partially degraded, still maintained the crystalline structure. The dissolved iron 
ions were retained around NP core as a ring, (Fig. 3c, d) most probably forming coordination 
complexes with the carboxylic groups of the polymer (Fig. S7). The impact of different 
accessibility of iron chelating agents to the iron oxide crystal on the degradation kinetics has 
been already highlighted.34,35 In this study nanocubes coated with PEG-gallol directly anchored 
to the iron oxide surface were found to degrade more rapidly and dissolve completely on the 
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contrast to the nanocubes embedded in an amphiphilic polymer shell similar to the one used here. 
This was explained by the fact that the polymer chains attached to discrete sites of the crystal 
surface could leave more access to the small citrate ions provoking accelerated degradation.  
 
Figure 3. In vitro degradation study of NPs@PMAO and NPs@PMAO-PC. (a) Representative 
TEM micrographs of the NPs@PMAO and NPs@PMAO-PC after incubation in water (upper 
row) and in lysosomes-mimicking medium (lower row). Scale bar 50 nm, scale bar of the insets 
10 nm. (b) Temperature dependence of the out-of-phase component of the AC magnetic 
susceptibility from NPs@PMAO and NPs@PMAO-PC incubated in the lysosomal medium (-
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lyso) or in water (control). (c) High Resolution-TEM micrograph of NPs@PMAO incubated in 
the lysosomal mimicking medium. Scale bar: 5 nm. (d) Scanning transmission electron 
microscope mode imaging of the same NPs. Scale bar: 20 nm. 
 
Further, to investigate if the differences in the PC composition between NPs@Glc and 
NPs@PEG influence on the degradation rate, both NPs types with PC were incubated in a 
lysosomal mimicking medium as described before. It was found by TEM that in only ten days of 
incubation, a significant part of the NPs@Glc was totally degraded losing their original shape, 
while most of the NPs@PEG remained unaffected (Fig. 4a). Those results were also confirmed 
by the AC magnetic measurements (Fig. 4b). Here the signal for NPs@Glc incubated in acidic 
medium was clearly moved towards lower temperatures on the contrary to the NPs@PEG one, 
indicating that the core of the first type of NPs has been modified. 
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Figure 4. In vitro degradation study of NPs@Glc and NP@PEG with their formed PCs 
(NPs@Glc-PC and NPs@PEG-PC, respectively). (a) Representative TEM micrographs of the 
NPs@Glc-PC and NPs@PEG-PC after incubation in water (upper row) and in lysosomes-
mimicking medium (lower row). Scale bar: 50 nm. (b) Temperature dependence of the out-of-
phase component of the AC magnetic susceptibility from NPs@Glc-PC and NPs@PEG-PC 
incubated in the lysosomal medium (-lyso) or in water (control). 
 
Those results are quite interesting, as both NPs types although are composed of exactly the same 
core and shell structure (Fig. S2a), present diverse degradation profiles in vitro. These results can 
be explained by the fact that as already described in the literature,36 the capping agents (in this 
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case glucose and PEG molecules used for the functionalization), influence on the different 
accessibility to the iron surface. In fact, also in this study we found that the NPs@Glc and 
NPs@PEG not bearing their PCs degraded with different kinetics in vitro (Fig. S8). However, 
the NPs@Glc without the adsorbed PC were found to be degraded to a greater extent than the 
same NPs bearing PC. By comparing TEM micrographs, it can be noticed that although some 
part of NPs@Glc-PC was degraded in the acidic environment, another part of those NPs 
preserved quite good their original morphology (Fig. 4a left upper corner of the NPs@Glc-
PC/lysosomal medium micrograph). On the other hand, almost all NPs@Glc incubated in the 
lysosomal medium were found degraded. Concordantly, the scaled χ″(T) maximum of the 
NPs@Glc-PC incubated in the acidic medium was shifted only to 90 K, whereas the same signal 
but for the NPs@Glc incubated in the acidic medium reached 40 K. Therefore, also in this case it 
was found, that PC can provide at least partial protection against degradation of the NP core.  
Interestingly, recent studies indicate that the accessibility to the iron surface may not only 
depend on the capping agent, but also on the composition of PC. In fact, proteins attached to the 
NPs can be digested in the lysosomal environment with different kinetics.7 It has been suggested 
that proteins of lower molecular weight would be degraded slower than others with higher 
molecular weights.37 Taking into account that both the attached molecule and the PC have an 
effect in the biodegradation in vitro, NPs@Glc and NPs@PEG were administrated in vivo to 
verify the biodistribution and biodegradation of NPs.  
In vivo biodistribution and toxicity study 
Despite the fact that IONPs are considered biocompatible, their safety may vary depending on 
different factors, such as: composition, physicochemical properties, route of administration or 
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dose range, and need to be revised on in vivo level, especially in the context of the little 
correlation that has been found between in vitro and in vivo studies.38,39 Therefore, NPs@Glc and 
NPs@PEG biodistribution and toxicity at short (72 h) and long term (four months) were 
analyzed employing 6-weeks old Swiss male and female individuals. The injected dose (0.1 
mmol Fe/kg animal) was similar to the dose of iron used as contrast agent in clinical magnetic 
resonance imaging.40,41 
Intravenous administration of both types of NPs did not affect animal body weight either in short 
(Fig. S9a) or long term (Fig. S9b) studies. Neither other symptoms of toxicity, effect on organs 
index (Fig. S10) nor tissue structural changes (Fig. S11 and S12) were found. Finally, four blood 
chemical parameters related to liver, kidney and muscle function (alanine aminotransferase 
(ALT), creatinine kinase (CK), creatinine and lactate dehydrogenase (LDH)) were analyzed, 
finding no significant variation with respect to control values (Fig. S13 and S14). Note that the 
results were the same for male and female animals in contrast to what it has been reported in 
other studies, where the toxicity induced by PEG-coated gold NPs was different depending on 
the animal gender.42 The rest of studies were only performed on female animals.  
NPs biodistribution 72 h post-injection 
As the IONPs were coated with a polymer shell modified with a fluorescent dye, their 
localization in selected organs ex vivo could be performed by examination of longitudinal tissue 
sections using fluorescence microscopy. 72 h after the administration of NPs@Glc, an intense 
and abundant fluorescence signal evidenced NPs accumulation mainly in the liver and spleen 
(Fig. 5). Whereas in the liver NPs were distributed homogenously throughout the tissue, in the 
spleen they were primarily observed in the red pulp and/or marginal zone.43 Also, a scarce signal 
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of NPs@Glc was found in the kidneys (Fig. 5). Interestingly, 72 h after administration 
NPs@PEG were detected in all examined organs (Fig. 5 and Fig. S15). The highest NPs@PEG 
accumulation was observed in the liver and spleen with homogenous distribution in both organs 
(Fig. 5) but also a quite significant amount was found in the reproductive organs, in both females 
and males. NPs@PEG in lower quantities were also localized in the kidneys, lungs, heart and 
thymus (Fig. S15). Of note, the disparate biodistribution profile for both NPs types could be 
specially appreciated in the spleen, where NPs@Glc were accumulated only in the red pulp 
and/or marginal zone, while NPs@PEG were homogenously distributed in the tissue.  
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Figure 5. Representative images of the biodistribution of NPs@Glc and NPs@PEG 72 h after 
administration in mice liver, spleen and kidneys analyzed by fluorescence microscopy ex vivo. 
Both NPs types were found mostly in the liver and spleen. For better visualization of NPs 
scarcely accumulated in the kidneys tissue (indicated by white arrows and enlarged in the left 
upper corner of each photo), fluorescence from the red channel has been superimposed with the 
one from the green channel. Control tissue sections originate from PBS treated mice. Cell nuclei 
were labeled with DAPI. Scale bar: 50 µm. 
 
Those results were confirmed by the AC magnetic measurements through the analysis of the out-
of-phase susceptibility (χ″(T)) profile, which allows to specifically identify and quantify the 
presence of superparamagnetic material, such as IONPs in biological matrices. In this case other 
iron-containing species (e.g. hemoglobin or ferritin) that are commonly present in tissue samples, 
do not contribute to the χ″(T) signal.44 This is a huge advantage over traditional methods for 
IONPs detection, such as elemental analysis or Prussian Blue staining, which fail to accurately 
quantify very small amount of iron from NPs due to a substantial amount of endogenous iron. As 
already suggested by the fluorescence microscopy, magnetic measurements confirmed that 
NPs@Glc were abundantly accumulated in the liver and spleen (Fig. 6a), whereas NPs@PEG 
were found in all analyzed organs, including lungs and heart (Fig. 6b). 
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Figure 6. IONPs detection by AC magnetic susceptibility in various tissues from mice 72 h after 
injection of (A) NPs@Glc. or (B) NPs@PEG. 
 
Additionally, the height of the out-of-phase susceptibility per mass of the tissue sample acts as a 
surrogate of the amount of NPs, therefore the amount of Fe in the tissue can be calculated (Table 
1). The abundant accumulation of NPs@Glc in the liver and spleen (3.8 and 1.7 higher in 
comparison with NPs@PEG, respectively, Table 1), suggests that NPs@Glc were rapidly 
recognized by macrophages and cleared from the blood, disabling accumulation in other organs. 
This hypothesis of fast clearance of NPs@Glc from the bloodstream by macrophages is 
supported by the in vitro studies performed with RAW 264.7 macrophages (Fig. S16), in which 
NPs@Glc and NPs@PEG bearing PC were incubated in serum-free conditions to avoid 
unspecific adsorption of proteins. If the proteins (i.e. opsonins) adsorbed in the PC are 
recognized by macrophages, are in the correct orientation and not masked with other proteins, 
they should be able to bind to macrophage receptors and be uptaken.45 Just two hours after 
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incubation we found that while NPs@PEG were not uptaken by the macrophages, NPs@Glc 
were highly uptaken. This confirms the results of the in vivo biodistribution, and has to be related 
with the different enrichment of proteins in each PC (as the amount of adsorbed proteins is 
similar), although their different orientation cannot be ruled out. Although coating of NPs with 
glucose significantly decreases the unspecific adsorption of model proteins46 and increases NPs 
uptake by cancerous cells in vitro (due to their elevated metabolic growth rate47 and/or 
expression of glucose transporters),48,49 in vivo studies demonstrate removal from the blood 
within an hour,50 scarce accumulation in the tumor tissue and rapid uptake by the liver and 
spleen,51 probably as a result of PC impact.  
Interestingly, it has to be highlighted that the composition of PC found in vitro where the ratio 
between albumin/complement proteins was nearly two times higher for NPs@PEG compared 
with NPs@Glc, positively correlated with the NPs behavior in vivo 72 h after injection.  
Table 1. Quantification of NPs@Glc and NPs@PEG accumulated in various mice organs 72 h 
post-injection calculated from the height of the tissue samples χ″ maxima. It has to be taken into 
account that as the total mass of the liver is several times higher than the spleen, the total amount 
of iron will be higher in the liver. 
 NPs@Glc NPs@PEG 
 
mg of Fe per kg of lyophilized 
tissue 
Liver 0,06 0,016 
Spleen 0,13 0,08 
Kidneys 0,02 0,007 
Lungs - 0,007 
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Heart - 0,003 
 
NPs biodistribution four months post-injection 
Once NPs are cleared from the blood and accumulated in organs, they undergo biotransformation 
processes, which may result in their degradation, assimilation and therefore elimination or 
persistence. Evaluation of NP behavior in a long time frame is necessary to encompass the whole 
NP lifecycle in vivo and predict potential exposure risk. In this case, AC magnetic measurements 
corroborated the results obtained from the fluorescence examination of tissue sections (Fig. S17 
and S18) showing that four months after the injection NPs@Glc were still present in the liver 
and spleen, whereas NPs@PEG were only present in the liver (Fig. 7). From the rest of the 
organs, both NPs types were cleared. From the relative height of the χ″(T) peak at four months, 
which was always smaller than the peak at 72 h (Fig 7. and Table 2), it was demonstrated that 
there was a general trend of NPs clearance in both liver and spleen.  
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Figure 7. Iron detection by AC magnetic susceptibility in the liver (upper row) and spleen (lower 
row) 72 h (blue line) and four months (red line) after the injection of NPs@Glc (left column) or 
NPs@PEG (right column). In all cases, four months after the administration the NPs clearance 
was detected as the χ″ (T) maximum height decreased in respect to the 72 h one. 
 
The liver showed 23 times fewer NPs@Glc compared to 72 h, while the spleen showed only 
three times signal reduction. That evidenced that NPs@Glc were cleared more efficiently from 
the liver than from the spleen. In the case of NPs@PEG, although the maximum χ″(T) for the 
liver decreased nearly 18 times when compared to 72 h signal, it was still present, whereas for 
Page 22 of 44
ACS Paragon Plus Environment
ACS Applied Materials & Interfaces
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
  
23
the spleen it almost disappeared. It is surprising that the degradation process in this case was 
faster in the spleen than in the liver, more particularly when the concentration in the spleen 72 h 
post-injection of NPs@PEG was 4.7 times higher compared to the liver. 
 
Table 2. Characteristics of the χ″(T) maximum for NPs@Glc and NPs@PEG accumulated in 
various mice organs 72 h and four months post injection. 
 
 χ″(T) maximum (m3/kg) 
 NPs@Glc NPs@PEG 
 72 h 4 months 72h 4 months 
Liver 1.2x10-7 5.2x10-9 3.2x10-8 1.9x10-9 
Spleen 2.5x10-7 7.9x10-8 1.5x10-7 - 
Kidneys 3.7x10-8 - 1.4x10-8 - 
Lungs - - 1.5x10-8 - 
Heart - - 6.7x10-9 - 
 
 
In summary, both NPs types showed, apart from diverse biodistribution pattern, different 
clearance rate. Whereas NPs@PEG were more efficiently cleared from the spleen, NPs@Glc 
clearance was more dynamic in the liver. In fact, faster clearance of NPs from liver has been 
described for many NPs types irrespectively of their core or coating.8,52,53 This is explained by 
the fact that the concentration per gram of organ is always higher in the spleen than in the liver. 
Therefore it is thought that the spleen degradation capacity may be saturated. However, this 
assumption finds a confirmation here only in the case of NPs@Glc and not NPs@PEG, as the 
latter were almost totally cleared from the spleen (Fig. 7). 
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To characterize the biodegradation of the NPs, the shift in temperature of the scaled χ″(T) 
maxima was studied (Fig. 8). In the case of NPs@PEG, there was a clear shift of the χ″(T) 
maximum from 60 K to 24 K over time (Fig. 8a). This indicates that most of the NPs@PEG in 
the liver underwent a transformation that could be associated with a reduction of NPs size, 
disaggregation, or both. In the case of the liver from the animals that received the NPs@Glc, the 
signal was broader, in particular towards lower temperatures (Fig. 8b). This could be interpreted 
as a fraction of the NPs being partially degraded while another fraction still remains not 
modified. In the spleen, NPs@Glc were scarcely transformed, as the maximum was only slightly 
shifted towards lower temperatures (Fig. 8c).  
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Figure 8. Tissue magnetic characterization. (a)-(c) Temperature dependence of the out-of-phase 
component of the AC magnetic susceptibility scaled to their maxima. (a) NPs@PEG in the liver, 
(b) NPs@Glc in the liver and (c) NPs@Glc in the spleen at different post-administration times 
(72 h and four months). 
 
If in the spleen the core of the NPs@Glc remained barely unmodified during the four months, the 
decrease of NPs concentration could be related to: i) a different degradation mechanism than in 
the liver, i.e. a small fraction of NPs are being degraded while the vast majority is unaffected; ii) 
an excretion of the NPs from the tissue, reducing the amount of NPs but not degrading them. 
As seen before, the PC of NP@Glc was enriched in opsonins when compared to the PC of 
NP@PEG that was more enriched in albumin. The fact that proteins from the PC can be 
degraded in lysosomes has been previously described.54 Further, Ma et al.7 described that the 
degradation rate of PC is dependent on the type of the protein. Specifically, in this study the 
protein coronas were formed using human serum albumin, γ-globulin, or serum fibrinogen. Their 
results indicate that the degradation is fastest for albumin corona and slowest for fibrinogen 
corona. In this case, NPs@PEG corona is enriched in albumin and therefore in vivo could be 
degraded faster. Further, only the PC of NPs@Glc contained fibrinogen, which could be 
indicative of a slower rate of degradation. 
Although partial degradation of NPs in vivo has been already observed in other works, a general 
trend cannot be ruled out due to the different methodologies, NPs, animal models or the time 
after injection. For instance, Kolosnijaj-Tabi et al.8 detected by TEM uneven dissolution of some 
gold-iron heterostructures one year after administration, while other NPs remained untouched, 
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suggesting that each heterostructure has its own kinetics of degradation. Similarly, when 
analyzing the biodegradation of iron oxide nanocubes, it was shown that some of them were 
found degraded already 14 days after injection, where others were untouched.34 The irregular 
petal-resemble shape of the heterostructures or unequal polymer shell coverage on the nanocubes 
edges may facilitate a different cellular medium penetration, leading to inconsistent degradation 
of the nanomaterial. However, these factors cannot be taken into account in the present study as 
interestingly differences in degradation have been observed between two NPs containing exactly 
the same core and polymer shell and differentiated only by the subsequent surface modification.  
The fact that in vivo NPs@PEG were cleared faster than NPs@Glc and completely transformed 
whilst in vitro where almost unmodified, may result from several reasons: i) in vitro the used 
medium does not exactly reproduce the lysosome conditions; ii) differences in the composition 
of the PC in vivo and in vitro that could ultimately affect the degradation rate of both PCs.7 iii) 
alternatively, the variation in the degradation rate could be related with the density of NPs in 
lysosomes. In fact, by TEM examination and X-Ray microanalysis (EDC) of tissue sections 
NPs@Glc were found to be tightly packed in the lysosomes of the spleen and liver cells on the 
contrary to NPs@PEG (Fig. 9 and Fig. S19-20). This could ultimately affect the degradation 
kinetics due to an unequal access of enzymes to the core.6 Although further research is needed to 
fully unravel these issues, we have demonstrated that in vivo studies are absolutely necessary in 
order to understand the long term degradation of NPs.  
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Figure 9. TEM micrographs of liver (upper row) and spleen (lower row) tissue of mice treated 
with NPs@Glc (left column) and NPs@PEG (right column) acquired in STEM mode. Note that 
NPs@Glc in both tissues are highly uploaded in vesicles on the contrary to NPs@PEG. Scale 
bar: 200 nm. STEM: scanning transmission electron microscopy. 
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CONCLUSIONS 
Before employing NPs in vivo, the parameters that affect their fate and degradation should be 
controlled. Using two NPs with identical core but different surface coating, we have shown that 
biodistribution and degradation over four months are completely different. In this case, a direct 
correlation between the PC composition in vitro and the fate of NPs in vivo was established. 
Moreover, it has been demonstrated that two parameters govern the NPs degradation in vitro: the 
surface coating, which influences the degradation rate, and the PC, which protects against NPs 
core degradation in acidic conditions.  
In vivo, it has been shown that NPs@PEG core suffered a faster degradation over time than 
NPs@Glc, in both liver and spleen. Interestingly, the degradation kinetics was different in the 
liver and spleen, depending on the NPs type. Although the degradation rate could be related to 
overlapping factors, these differences can still have their primary origin in the PC, whose 
composition drives NPs fate and may also influence on the degradation rate in the lysosomes. 
For the first time it has been demonstrated that the biodegradation process is not only related 
with the NPs core and shell, but also with the surface coating, and therefore the associated PC. 
Further research will increase our understanding of NPs biodegradation associated to PC, 
opening the way to adopt strategies to control NPs behavior on the long-term frame. 
 
METHODS 
Chemicals. Unless otherwise stated, all reagents were purchased from Sigma-Aldrich (MO, 
USA). 
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NPs functionalization. Fluorescent NPs were obtained by modifying the PMAO polymer with 
tetramethylrhodamine 5(6)-carboxamide cadaverine (TAMRA; Anaspec [Seraing, Belgium]). As 
already reported,16 1% of the polymer monomers were modified with TAMRA before 
transferring the MNPs into water. Functionalization with glucose or PEG (MW = 5000 Da) was 
performed by incubating 1 mg of Fe with 42 µmol of N-(3-dimethylaminopropyl)-N´-
ethylcarbodiimide hydrochloride (EDC), 30 µmol of 4-aminophenyl β-D-glucopyranoside or 
12.5 µmol of α-methoxy-ω-amino poly(ethylene glycol) 5000 Da (Iris Biotech GmbH 
[Marktredwitz, Germany]) in 250 µL of SSB buffer pH 9 (50 mM of boric acid and 50 mM of 
sodium borate). After 3 h of incubation, the ligand excess was removed by washing the MNPs 
with phosphate-buffered saline (PBS) pH 7.4 in a centrifugal filter with a membrane of 100 kDa 
molecular weight limit (Merck Millipore, Darmstadt, Germany). 
Protein corona characterization. Protein corona formation. 0.25 mg of Fe of each NP type 
(NPs@PMAO, NPs@Glc, NPs@PEG) was incubated for 3 h at 37 ºC with 775 µg of serum 
proteins in a final volume of 500 µL by adding 10 mM HEPES pH 7.4. Afterwards, the samples 
were washed twice in 500 µL of 10 mM MES pH 7.4 by ultracentrifugation at 18000 × g at 4 ºC 
for 1 h. The isolation of proteins bound on the NPs was performed by SDS buffer elution 
protocol.55 Briefly, after the last wash, NPs were suspended in 250 µL of 1% SDS and 100 mM 
Tris buffer (pH 7.4) for 1 h at room temperature to elute the bound proteins from the NPs. Then 
the NPs were removed from the elution buffer via centrifugation at 16 000 ×g at 4 ºC for 60 min. 
About 1 mL of cold acetone was added to the eluent and kept at -20 ºC overnight to precipitate 
the proteins. After centrifugation and drying the acetone from the tube, the protein pellet was 
dissolved in 6 M Urea (GE Healthcare, Little Chalfont, UK) and 50 mM ammonium bicarbonate 
by vortexing and brief sonication.  
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Digestion procedure. After protein quantification (see the supporting information), 20 µg of each 
NP bound protein sample was subjected to tryptic digestion. Each protein sample was reduced by 
10 mM DTT for 1 h at room temperature, then alkylated with 30 mM IAA for 30 minutes in dark 
and finally reaction was stopped by the addition of 37.5 mM N-Acetyl-L-cysteine (NAC) for 15 
minutes at room temperature. About 2 µg Trypsin Gold, MS Grade (Promega Biotech, 
Wisconsin, USA) was added to digest proteins overnight at 37 ºC. 
Liquid chromatography-Mass spectrometry analysis (LC-MS). Tryptic digests were analyzed 
using a linear ion trap Velos-Orbitrap mass spectrometer (Thermo Fisher Scientific, Bremen, 
Germany). Instrument control was performed using Xcalibur software package, version 2.1.0 
(Thermo Fisher Scientific, Bremen, Germany). Peptide mixtures were fractionated by on-line 
nanoflow liquid chromatography using an EASY-nLC system (Proxeon Biosystems, Thermo 
Fisher Scientific) with a two-linear-column system. Digests were loaded onto a trapping guard 
column (EASY-column, 2 cm long, ID 100 µm and packed with Reprosil C18, 5 µm particle size 
from Proxeon, Thermo Fisher Scientific) at a maximum pressure of 160 bar. Then, samples were 
eluted from the analytical column (EASY-column, 10cm long, ID 75 µm and packed with 
Reprosil, 3 µm particle size from Proxeon, Thermo Fisher Scientific). Separation was achieved 
by using a mobile phase from 0.1% FA (Buffer A) and 100 % acetonitrile with 0.1 % FA (Buffer 
B) and applying a linear gradient from 5 to 35 % of buffer B for 90 min at a flow rate of 300 
nL/min. Ions were generated applying a voltage of 1.9 kV to a stainless steel nano-bore emitter 
(Proxeon, Thermo Fisher Scientific), connected to the end of the analytical column. The LTQ 
Orbitrap Velos mass spectrometer was operated in data-dependent mode. A scan cycle was 
initiated with a full-scan MS spectrum (from m/z 300 to 1600) acquired in the Orbitrap with a 
resolution of 30000. The 20 most abundant ions were selected for collision-induced dissociation 
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fragmentation in the linear ion trap when their intensity exceeded a minimum threshold of 1000 
counts, excluding singly charged ions. Accumulation of ions for both MS and MS/MS scans was 
performed in the linear ion trap, and the AGC target values were set to 1 × 106 ions for survey 
MS and 5000 ions for MS/MS experiments. The maximum ion accumulation time was 500 and 
200ms in the MS and MS/MS modes, respectively. The normalized collision energy was set to 
35%, and one microscan was acquired per spectrum. Ions subjected to MS/MS with a relative 
mass window of 10 ppm were excluded from further sequencing for 20 s. For all precursor 
masses a window of 20 ppm and isolation width of 2 Da was defined. Orbitrap measurements 
were performed enabling the lock mass option (m/z 445.120024) for survey scans to improve 
mass accuracy.56 
Protein Identification. LC-MS/MS data was analyzed using the Proteome Discoverer 1.2 
software (Thermo Fisher Scientific) to generate mgf files. Processed runs were loaded to 
ProteinScape software (Bruker Daltonics, Bremen, Germany) and proteins were identified using 
Mascot (Matrix Science, London UK).  MS/MS spectra were searched with a precursor mass 
tolerance of 10 ppm, fragment tolerance of 0.5 Da, trypsin specificity with a maximum of 2 
missed cleavages, cysteine carbamidomethylation set as fixed modification and methionine 
oxidation as variable modification.  Identifications were filtered at 1% False Discovery Rate 
(FDR) at peptide level.  
Signaling pathways analysis. To identify biological functions enriched within our set of unique 
identified proteins, the UniProt IDs corresponding to exclusive identified proteins adsorbed to 
NPs@PEG and NPs@Glc were uploaded and mapped into the Ingenuity Pathway Analysis 
(IPA) software (QIAGEN, Redwood City, CA, USA). The Molecular and Cellular Functions 
lists were generated and Venn diagram was used to analyze the matching functions 
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In vitro degradation study of NPs. NPs at equals concentrations (0,1 mg/mL; 46 µg of Fe) were 
incubated in lysosomal mimicking medium containing citric acid 4.4 mM and sodium citrate 
tribasic dihydrate 5.6 mM pH 4.7 at room temperature. NPs@Glc and NPs@PEG were incubated 
for ten days, whereas NPs@PEG for two months. As a control NPs were left for the same period 
of time in water. Afterwards, all samples were centrifuged at 21920 x g for 1 h at 4 °C. The 
supernatant was discarded as the NPs were resuspended in water for further TEM, HR-TEM, 
STEM or AC magnetic measurements. TEM analysis were carried out using a Tecnai T20 (FEI, 
Netherlands) transmission electron microscope working at 200 kV. HT-TEM analysis was 
performed on Tecnai F30 (FEI company, Netherlands) transmission electron microscope 
working in TEM or Scanning-Transmission (STEM) mode and equipped in X-Ray 
Microanalysis (EDS) which was used for spectroscopy experiment. The magnetic 
characterization was performed in a Quantum Design MPMS-XL and MPMS-5S SQUID 
magnetometers equipped with an AC (Alternating Current) magnetic susceptibility option. The 
NPs were placed in polycarbonate capsules and the measurements were performed with AC 
amplitude of 0.41 Oe, in the temperature range between 2 and 300 K and at a frequency of 11 
Hz.  
Animal experimentation. All the experiments carried out on animals were accepted by the 
Ethics Advisory Committee for Animal Experimentation of the University of Zaragoza and 
performed according to the institutional animal use and care regulation of the Centro de 
Investigación Biomédica de Aragón (CIBA; Zaragoza, Spain). The animals were purchased from 
the CIBA center and fed a standard diet ad libitum throughout the experiments. Pathogen-free 
female 6-week-old Swiss mice (mean weight 29.51±3.12 g) were randomly divided into three 
different groups: mice injected with NPs@Glc or NPs@PEG, and control group where PBS was 
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injected. To reach statistically significant results, each group consisted of five animals, 
experiments were performed using male and female animals and repeated twice. NPs@Glc and 
NPs@PEG were suspended in 100 µL of PBS and injected intravenously in the tail vein at dose 
of 0.1 mmol of Fe per kg (injected dose 3 µmol/animal). Mice were sacrificed 72 h and four 
months after the injection in CO2 gas chamber. Subsequently the blood has been collected by 
cardiac puncture using 10% of sodium citrate as anticoagulant for plasma separation via 
centrifugation (15 min, 2000 x g). The samples were left to clot at room temperature for 30 min 
and then, serum were removed and stored at –80 °C for later analyses. ALT (alanine 
aminotransferase), and CK (creatine kinase), activities were measured according to the IFCC 
recommendations, by means of the decrease (ALT) or increase (CK) of absorbance at 340 nm. 
Determination of LDH (lactate dehydrogenase) activity was measured by the transformation of 
lactate to piruvate, measuring the increase of absorbance at 340 nm. Creatinine concentrations 
were determined by the Jaffé method. All measurements were carried out using an automated 
analyzer (Cobas c501, Roche Diagnostics). Finally liver, spleen, kidneys, heart, lungs, thymus 
and reproductive organs were excised and prepared for fluorescent microscopy examination, 
histopathological tissue examination (in the ESEM), TEM and AC magnetic measurements.  
Fluorescence microscopy examination of tissue sections. NPs localization in tissues of excised 
organs has been examined by fluorescence microscopy owing to the presence of TAMRA 
fluorophore coupled to the PMAO polymer surrounding NPs. For that purpose pieces of all 
before mentioned organs were fixed with pH 7.4 phosphate-buffered 4% paraformaldehyde 
during 24 h at 4 °C and processed in mesh cassettes (Mesh Biopsy Cassette) using a standard 
protocol (automatic tissue processor; Tissue-Tek Xpress x50). The preparation of the blocks was 
carried out with the block making unit (Leica EG1150) after which the blocks were solidified on 
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a cold plate. Samples were embedded in paraffin, sectioned at three microns thick (Rotary 
microtome Leica RM2255) and placed in a tempered bath where they were collected with 
Superfrost slides (Dako Flex IHC Microscope Slides; ref: K8020). The slides were placed in 
vertical racks and allowed to dry in an oven. Afterwards, a process of dewaxing and hydration 
was performed for subsequent staining with 4,6-diamidino-2-phenylindole (DAPI). The samples 
were mounted directly using DAPI - Fluoromount - G (SouthernBiotech; Ref 0100-20) and 
examined under inverted microscope (Nikon Eclipse Ti-E, Amsterdam, The Netherlands). 
TEM characterization of organs. For electron microscopic analysis, the excised organs were 
cut into 1 mm3 pieces and fixed with 2.5% glutaraldehyde/2% paraformaldehyde in 0.1 M pH 7.4 
sodium phosphate buffer for 24 h at room temperature and subsequently for 5 days at 4 °C. 
Following, the samples were washed for 30 min four times with sodium phosphate buffer, post-
fixed with 2% osmium, rinsed, dehydrated and embedded in Durcupan resin (Fluka, Sigma-
Aldrich, St. Louis, USA). Semithin sections (1.5 µm) were cut with an Ultracut UC-6 (Leica, 
Heidelberg, Germany) and stained lightly with 1% toluidine blue. Finally, ultra-thin sections 
(0.08 µm) were cut with a diamond knife, stained with lead citrate (Reynolds solution) and 
examined under a 300 kV transmission electron microscope FEI Tecnai F30  (FEI company, 
Netherlands) enabling working in STEM mode and performing EDS. 
Magnetic characterization of organs. Tissue samples were freeze-dried in Telstar cryodos-50 
during 24 h. Pieces of the different tissues were directly placed in gelatin capsules for their 
magnetic characterization. Spleen samples presented the lowest weights (2.5 – 7.5 mg) while the 
bigger volume of the livers allowed a bigger amount of tissue to be characterized (88 – 95 mg). 
The low amount of spleen sample results in noisier magnetic measurements in comparison with 
the livers. 
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The magnetic characterization was performed in a Quantum Design MPMS-XL and MPMS-5S 
SQUID magnetometers equipped with an AC (Alternating current) magnetic susceptibility 
option. The measurements were performed with AC amplitude of 0.41 Oe, in the temperature 
range between 2 and 300 K and at a frequency of 11 Hz.  
NPs@Glc and NPs@PEG were characterized in the same conditions, by placing a known 
volume of the injected particles into polycarbonate capsules, in order to use the data as standards 
for the quantification of the amount of NPs in each tissue. Magnetic nanoparticle quantification 
in tissue samples was performed following the protocol previously described.57 
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